ArticleMedical mycology2025
Sporothrix davidellisii : A new pathogenic species belonging to the Sporothrix pallida complex.
Article in Medical mycology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Molecular detection of medically relevant Sporothrix species in roadkilled wildlife in the Brazilian Atlantic forest.Mycopathologia · 2026Article
- First report of sporotrichosis byMedical mycology case reports · 2025Article
- Cryptic Diversity and Ecological Overlap inJournal of fungi (Basel, Switzerland) · 2025Article
- Prospective Uncontrolled Interventional Study of Itraconazole and β-Glucans (Veterinary sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Sporothrix species (Ascomycota, Ophiostomatales) are dimorphic fungi with diverse ecological niches, ranging from mammalian, plant, and insect pathogens to fungicolous organisms. Here, we describe Sporothrix davidellisii (CBS 147636T), a novel pathogenic species within the S. pallida complex isolated from a case of feline sporotrichosis in Melbourne, Australia. Phylogenetic analyses based on ITS, β-tubulin (BT2), calmodulin (CAL), and translation elongation factor 1-α (EF1-α) sequences confirmed its distinctiveness, with ITS sequence identity to its closest relative (S. chilensis) not exceeding 97.6%. The assembled genome is 39.02 Mb (eight contigs) with a 27.2 kb mitochondrial genome and a total of 12,631 predicted genes. Genetic diversity analyses revealed moderate nucleotide variation in the ITS region (π = 0.055), greater diversity in BT2 (π = 0.098), and CAL (π = 0.118), supporting its status as a unique species. Morphological studies revealed distinctive characteristics differentiating S. davidellisii from its nearest relatives, including elongated clavate sympodial conidia and sessile conidia. Notably, S. davidellisii exhibits yeast-like growth at 37°C, forming ellipsoid to ovoid budding cells in liquid media, although cigar-shaped yeasts, characteristic of highly virulent Sporothrix species, are rarely observed. This ability to transition to a yeast-like form, combined with its high-temperature tolerance (growth up to 40°C), underscores its opportunistic pathogenic potential. The pathogenic role of S. davidellisii highlights the importance of monitoring atypical Sporothrix infections in feline hosts, which may serve as environmental sentinels for emerging fungal pathogens. These findings expand the taxonomy of Sporothrix, contributing to our understanding of the evolutionary complexity and zoonotic potential of species within the S. pallida complex.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.